# DESCRIPTION

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND OF THE INVENTION

- motivate neurodegenerative diseases
- describe limitations of current treatments
- introduce direct reprogramming of cells

## SUMMARY OF THE INVENTION

- introduce induced dopaminergic precursor
- describe ectopically expressed genes
- outline uses of induced dopaminergic precursor
- summarize methods of transdifferentiation

## DETAILED DESCRIPTION OF THE INVENTION

- introduce compositions and methods for transdifferentiation of somatic cells
- describe ectopic expression of Brn2, Sox2, and Foxa2 for direct reprogramming of terminally differentiated cells
- highlight advantages of the present disclosure over currently available technologies

### Definitions

- define transdifferentiation and reprogramming
- define somatic cell
- define dopaminergic precursor (DP) cell
- define endogenous DP cell
- define induced dopaminergic precursor (iDP) cell
- define ectopic expression
- define expression and expression products
- define Brn2, Brn4, Sox2, Foxa2, and Lmx1a
- define variant, fragment, and derivative of polypeptides
- define operably linked
- define viral vectors
- define transcription factor
- define decrease, reduced, reduction, inhibit
- define increased, increase, enhance, activate
- define subject, individual, patient
- define treat, treating, treatment
- define comprising, consisting essentially of, consisting of, about, a, or, and/or

### Somatic Cells

- describe primary somatic cell types that can be used

### Reprogramming (Transdifferentiation)

- define transdifferentiation
- describe master transcription factors for iDP
- outline methods for increasing expression level of master TFs
- describe ectopic expression of master TFs
- discuss endogenous gene expression modification
- mention applications of transdifferentiated cells
- describe use of transdifferentiated cells in screening methods

### iDP Production

- introduce midbrain dopaminergic neuron degeneration in Parkinson's disease
- describe limitations of current therapeutic strategies
- propose direct conversion of fibroblasts into iDPs
- describe Foxa2's role in midbrain DA neuron development
- outline initial studies on converting fibroblasts into iNPCs
- describe Foxa2 and Lmx1a's role in DA neuronal fate
- outline experimental design for Foxa2 and Lmx1a overexpression
- describe results of Foxa2 and Lmx1a overexpression
- propose Foxa2's role in specifying mesencephalic dopaminergic progenitor identity
- describe experimental design for direct conversion of fibroblasts into iDPs
- characterize iDPs through marker gene expression
- describe iDPs' dopaminergic neuronal-restricted differentiation potential
- discuss functional properties of iDP-derived DA neurons

### Human iDP Upon Ectopic Expression of Brn2, Sox2 and Foxa2

- describe transdifferentiation of human fibroblasts into iDPs

## DISCUSSION

- introduce stem cell-based therapy for PD
- motivate direct conversion of cells into DA neurons
- discuss limitations of previous studies
- introduce Foxa2 and Lmx1a as key transcription factors
- describe the role of Foxa2 in midbrain DA progenitor specification
- summarize the results of the study
- highlight the potential of iDPs as a cell source for PD treatment

## Methods

### Cell Preparation, Retroviral Packaging, Infection and Direct Reprogramming

- describe cell preparation and retroviral packaging
- outline the direct reprogramming process

### Quantitative Real-Time RT-PCR

- describe the RT-PCR analysis

### Immunocytochemistry

- outline the immunocytochemistry protocol

### Differentiation

- describe astrocyte and oligodendrocyte differentiation
- outline neuronal differentiation protocols

### Recording of Action Potentials and Total Currents

- describe the whole cell patch-clamp technique
- outline the recording of action potentials
- describe the measurement of total currents

### Motor Function and Behavior Tests

- describe the rotarod test

### Statistical Analysis

- outline the statistical analysis methods

### Cell Labeling, Transplantation and Histology

- describe cell labeling and transplantation
- outline the histology protocol

